The landscape of dementia analysis has advanced drastically with the appearance of refined biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly assessments that can detect Alzheimer's pathology a long time right before signs emerge. When these technological advances symbolize extraordinary progress in knowing neurodegenerati